Kisunla (Donanemab): A Novel Breakthrough Illuminating a Path to Better Alzheimer’s Outcomes
Alzheimer’s disease (AD) is a progressive neurodegenerative condition marked by cognitive decline, memory loss, and loss of independence.
Research & Reviews: Journal of Neuroscience [2277-6427(e)] is a peer-reviewed hybrid open access journal launched in 2011 and focused on the rapid publication of fundamental research papers on all areas of neurosciences. The scope of neuroscience …
rrjons maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.

Alzheimer’s disease (AD) is a progressive neurodegenerative condition marked by cognitive decline, memory loss, and loss of independence.
The long-term, irreversible brain disorder “Alzheimer’s disease (AD)” currently has no known cure. Nonetheless, current medications may impede their advancement.
Parkinson’s disease (PD) is a long-term, progressive neurodegenerative disorder that mainly occurs in people older than 60 years, affecting nearly 1% of this population.
Alzheimer’s disease (AD) is a neurological condition that worsens with time and impairs a patient’s quality of life by causing cognitive loss.
Forward Head Posture (FHP) is a common postural disorder in young adults, often exacerbated by extended screen time and poor ergonomic practices.
Past Life Regression (PLR) is a controversial therapeutic approach. It is done through hypnosis, which recovers memories of previous lives.